Upregulation of MiR-340-5p Reverses Cisplatin Sensitivity by Inhibiting the Expression of CDK6 in HepG2 Cells

Tian, S; Liu, Z; Zhou, Q; Wu, RX; Huang, XD; Liang, ZC; Zhang, Z; Tian, XF

Tian, XF (corresponding author), Hunan Univ Chinese Med, Coll Integrated Chinese & Western Med, 300 Xuanpu Sci & Educ Yuan, Changsha 410208, Hunan, Peoples R China.

FOLIA BIOLOGICA-KRAKOW, 2021; 69 (2): 57

Abstract

Cisplatin (CDDP) has been successfully used in chemotherapy for liver cancer. However, the development of CDDP resistance in HepG2 cells usually leads......

Full Text Link